JP Morgan Chase & Co’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.15K | Buy |
|
|||||
|
2025
Q2 | $1.69K | Sell |
|
|||||
|
2025
Q1 | $17.2K | Sell |
|
|||||
|
2024
Q4 | $155K | Sell |
|
|||||
|
2024
Q3 | $238K | Buy |
|
|||||
|
2024
Q2 | $30.4K | Buy |
|
|||||
|
2024
Q1 | $35.5K | Sell |
|
|||||
|
2023
Q4 | $164K | Buy |
|
|||||
|
2023
Q3 | $254K | Buy |
|
|||||
|
2023
Q2 | $89.8K | Buy |
|
|||||
|
2023
Q1 | $84K | Buy |
|